Abstract:A panel of experts recently completed updating the European Guidelines for the use of Ultrasound Contrast Agents. It is due to be published in early 2008 and updates and extends the 2004 Guidelines, which covered only the liver. The new liver section, which includes the use of USCM in interstitial ablation, incorporates the recent Barcelona guidelines for management of focal lesions discovered during ultrasound surveillance in cirrhotic patients. Though focussed on SonoVue, it forms a useful framework for a general discussion of this topic. It also covers clinically established uses in the kidneys and pancreas, in abdominal trauma, in vesico-ureteric reflux and in transcranial studies. The liver section of the guidelines opens with a rationale for beginning with characterisation of focal lesions rather than their detection, as may seem logical. This points up a fundamental awkwardness of the way USCM work in the liver: the initial arterial phase is particularly useful for differentiating between various focal lesions, while the late (sinusoidal) phase is critical for determining the malignant nature of solid liver lesions. Benign lesions such as haemangiomas and focal nodular hyperplasia have a rich arterial supply and often enhance early in the arterial phase. In haemangiomas, the blood enters the lakes that constitute the abnormality at the periphery of the lesion, giving rise to peripheral nodular enhancement. From here, it percolates towards the centre of the haemangioma, usually fairly slowly, taking up to five minutes to fill completely. At this stage, the lesion disappears as it matches the intensity of the enhanced liver parenchyma, though the process is incomplete in haemangiomas that contain thrombus, usually larger lesions. Thus, delayed scanning is required to confirm that the lesion has disappeared or at least become smaller. FNHs also have an arterial supply via one or several tortuous feeding vessels. However, the flow pattern is distinctive, arriving first at the centre of the lesion and filing it in a centrifugal fashion, often forming a spoke wheel pattern. The enhancement is often intense and very rapid (the “light bulb sign”) and so the early images after arrival of the contrast are critical; the study should be recorded so that these early frames can be reviewed, if necessary in slow motion, to allow the characteristic pattern to be recognised. In the late phase, FNHs disappear as the liver enhancement matches the enhancement in the lesion. In around a quarter of cases, the central scar becomes visible in this phase as a stellate central filling defect. For both lesions, these features carry the same confidence as the equivalent CT or MR haemodynamic findings and do not require further investigation when they are typical, as is the case in around 75% of cases. Atypical cases, which amount to 5 or 10%, require further investigation. Other lesions with diagnostic haemodynamic patterns are focal fatty sparing and change as well as regenerating nodules: they have normal haemodynamics and so behave in exactly the same way as the surrounding liver, disappearing in the late phase. Hepatic adenomas seem to have a variety of patterns, but experience with them is still limited, as it is for other uncommon focal lesions such as granulomas and peliosis.

CT Diagnosis of Local Liver Fat Deposition

[Correlation Between Pathology and Imaging Characteristics of Hepatic Agiomyolipoma].

Virtual non-contrast of liver from dual energy CT: a clinical application

Real Time Contrast-Enhanced Ultrasound in Diagnosis of Liver Localized Fatty Deletion and Fatty Infiltration

Correlation between Non-Alcoholic Fatty Liver Disease and Visceral Adipose Tissue in Non-Obese Chinese Adults: A CT Evaluation.

Comparative the Clinical Value of Contrast-Enhanced Ultrasonography, Enhancement CT and MRI for Diagnosing of Liver Lesions.

CT Manifestations and Differential Diagnosis for Mass-like Hepatic Lesion

Imagiologic Features and the Relative Imaging Factors in Hepatolenticular Degeneration

CT Findings and Significance of Hepatic Perfusion Disorders

Detection of fatty liver using virtual non-contrast dual-energy CT

MSCT Study on Focal Nodular Hyperplasia in Liver

The Analysis of CT and MRI Appearances of Hepatic Angiomyolipomas

Ultrasound Diagnostic Analyses of Liver Lesion with Calcification

Diagnosis of the hepatic focal nodular hyperplasia by ultrasonography and CT

Comparison and correlation of CT scan and MRI for focal liver lesion detection and characterization

CT diagnosis of hepatic cholangiocarcinoma

Imaging Analysis of Focal Nodular Hyperplasia of Liver

- 32S 2-1 9 th US Contrast The Diagnosis of Liver Tumours with Ultrasound Contrast

CT Features and Pathological Analysis of Abdomen Fat Necrosis Correlated with Non-acute Pancreatitis

Role of Imaging Techniques in Clinical Research and Practice on Nonalcoholic Fatty Liver Disease

Localized Castleman′s Disease of the Abdomen:Ct and Histo-Pathologic Correlation